MMP Control
-
MMP Control (5)
-
6-epi Doxycycline
0 Images6-Epi-doxycycline is the C-6 epimer of Doxycycline (HY-N0565), formed as a degradation impurity through epimerization of Doxycycline under abnormal conditions (e.g., high temperature, pH changes, or humidity). 6-Epi-doxycycline is commonly used for the detection and analysis of impurity levels in pharmaceutical formulations.
-
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -
-
(R)-Prinomastat
0 Images別名: (R)-AG3340; (R)-KB-R9896(R)-Prinomastat ((R)-AG3340) is the R-isomer of Prinomastat (HY-12170) (a MMP Inhibitor).
-
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -
-
Antitumor agent-173
0 Images製品番号: HY-161821Antitumor agent-173 (Compound 4b) is a prodrug of Cycloicaritin (HY-N1940). Antitumor agent-173 is a substrate for OATP2B1. Antitumor agent-173 selectively inhibits the growth of tumor Antitumor agent-173 significantly increases the oral bioavailability of Cycloicaritin and exerts good antitumor activity and safety.
-
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -
-
(R)-TAPI-2
0 Images製品番号: HY-100211ACAS 番号: 689284-12-6別名: (R)-TNF Protease Inhibitor 2(R)-TAPI-2 is the isomer of TAPI-2 (HY-100211A). TAPI-2 (TNF Protease Inhibitor 2) is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20 μM for MMP. TAPI-2 blocks the entry of infectious SARS-CoV.
-
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -
-
(2R)-RXP470.1
0 Images製品番号: HY-135517A純度: 98.70%別名: (2R)-RXP-470(2R)-RXP470.1 ((2R)-RXP-470) is the (2R)-isomer of RXP470.1 (HY-135517). RXP470.1 (RXP-470) is a potent, selective MMP-12 inhibitor with a Ki of 0.2 nM against human MMP-12.
-
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -